Contact and support
Need help, have a question, or want to contact the ResearchHub team?
© 2026 ResearchHub. Built for responsible scholarly connection.
Privacy-aware community infrastructureResearch graph
References from Autoimmune disorders and cardiovascular disease: a matched cross-sectional analysis of disease-specific associations in Qatari primary care. Local targets link to admitted publications; unresolved targets remain external evidence.
Risk of cardiovascular mortality in patients with rheumatoid arthritis: a meta-analysis of observational studies
2012 · External reference
Sex-specific differences in the presentation of cardiovascular disease in systemic lupus erythematosus
2016 · External reference
Age-specific incidence rates of myocardial infarction and angina in women with systemic lupus erythematosus: comparison with the Framingham study
10.1093/oxfordjournals.aje.a009122 · 1997 · External reference
Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosis
2010 · External reference
Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosus
10.1056/nejmoa035471 · 2003 · External reference
The impact of biologic therapies on cardiovascular risk in rheumatoid arthritis: a systematic review and meta-analysis
2017 · External reference
Comparative cardiovascular risk of methotrexate versus anti-tumor necrosis factor-alpha agents in patients with rheumatoid arthritis
2015 · External reference
Subclinical hypothyroidism and the risk of coronary heart disease and mortality
10.1001/jama.2010.1361 · 2010 · External reference
Clinical application of c-reactive protein for cardiovascular disease detection and prevention
10.1161/01.cir.0000053730.47739.3c · 2003 · External reference
Comparison of c-reactive protein and low-density lipoprotein cholesterol levels in the prediction of first cardiovascular events
10.1056/nejmoa021993 · 2002 · External reference
C-reactive protein modulates risk prediction based on the Framingham score: results from a large cohort study in southern Germany
10.1161/01.cir.0000120707.98922.e3 · 2004 · External reference
C-reactive protein and risk of cardiovascular disease in men and women from the Framingham heart study
10.1001/archinte.165.21.2473 · 2005 · External reference
The role of c-reactive protein or erythrocyte sedimentation rate in predicting cardiovascular outcomes in rheumatoid arthritis: analysis of data from US managed care organization
10.1136/annrheumdis-2014-eular.1742 · 2014 · External reference
Performance of the Framingham cardiovascular risk prediction model with and without c-reactive protein or erythrocyte sedimentation rate in ra: analysis of us electronic medical records database
10.1136/annrheumdis-2014-eular.1833 · 2014 · External reference
Levels of c-reactive protein associated with high and very high cardiovascular risk are prevalent in patients with rheumatoid arthritis
10.1371/journal.pone.0006242 · 2009 · External reference
Obesity in the qatari population: an epidemiological perspective
2016 · External reference
Core health indicators in countries with high proportion of expatriates: case study of Qatar
10.3389/fpubh.2023.1035686 · 2023 · External reference
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
10.1016/j.jclinepi.2019.02.004 · 2019 · External reference
Logistic regression was as good as machine learning for predicting major chronic diseases
10.1016/j.jclinepi.2020.03.002 · 2020 · External reference
Understanding the epidemiological characteristics of the primary healthcare corporation-based COVID-19 swabbed persons in Qatar, 2020
2022 · External reference
Health risk factors, status and service utilisation of adults in primary health care settings in Qatar: the Healthsight study protocol
10.1371/journal.pone.0304160 · 2024 · External reference
Epidemiology and utilization of primary health care services in Qatar by asthmatic children 5–12 years old: secondary data analysis 2016–2017
10.1186/s40733-019-0050-4 · 2019 · External reference
Missing clinical and behavioral health data in a large electronic health record (ehr) system
10.1093/jamia/ocw021 · 2016 · External reference
Strategies for handling missing data in electronic health record derived data
10.13063/2327-9214.1035 · 2013 · External reference
Unresolved reference
1987 · External reference
Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach
10.2307/2531595 · 1988 · External reference
Evaluating the added predictive ability of a new marker: from area under the ROC curve to reclassification and beyond
10.1002/sim.2929 · 2008 · External reference
Index for rating diagnostic tests
10.1002/1097-0142(1950)3:1<32::aid-cncr2820030106>3.0.co;2-3 · 1950 · External reference
Estimation of relative risk from matched pairs of cases and controls
1978 · External reference
Comparison of conditional and unconditional logistic regression for matched case-control studies
2018 · External reference
What does the odds ratio estimate in a case-control study?
10.1093/ije/22.6.1189 · 1993 · External reference
The bimodal mortality pattern of systemic lupus erythematosus
10.1016/0002-9343(76)90431-9 · 1976 · External reference
Traditional Framingham risk factors fail to fully account for accelerated atherosclerosis in systemic lupus erythematosus
10.1002/1529-0131(200110)44:10<2331::aid-art395>3.0.co;2-i · 2001 · External reference
Atherosclerotic cardiovascular disease in systemic lupus erythematosus
2013 · External reference
Type i interferons modulate vascular function, repair, thrombosis, and plaque progression in murine models of lupus and atherosclerosis
10.1002/art.34504 · 2012 · External reference
Antiphospholipid antibodies and the risk of cardiovascular disease: insights from the systemic lupus erythematosus cardiovascular disease study
2007 · External reference
Biomarkers of premature atherosclerosis in systemic lupus erythematosus
2007 · External reference
Oxidized low-density lipoprotein/beta2-glycoprotein i complexes and autoantibodies in patients with systemic lupus erythematosus and antiphospholipid syndrome
2006 · External reference
Association between changes in disease activity and subsequent changes in inflammatory markers: a longitudinal study
2012 · External reference
Leptin is associated with presence and severity of coronary atherosclerosis in patients with systemic lupus erythematosus
2014 · External reference
Proinflammatory high-density lipoprotein as a biomarker for atherosclerosis in patients with systemic lupus erythematosus and rheumatoid arthritis
10.1002/art.21976 · 2006 · External reference
Risk of subclinical atherosclerosis in patients with antiphospholipid syndrome and subjects with antiphospholipid antibody positivity: a systematic review and meta-analysis
10.1016/j.cpcardiol.2023.101672 · 2023 · External reference
Cardiovascular morbidity and mortality in rheumatoid arthritis
2008 · External reference
Rheumatoid arthritis and cardiovascular disease
2018 · External reference
Trends in cardiovascular mortality in patients with rheumatoid arthritis over 50 years: a systematic review and meta-analysis of cohort studies
10.1093/rheumatology/kep252 · 2009 · External reference
Autoimmune diseases and cardiovascular risk: a population-based study on 19 autoimmune diseases and 12 cardiovascular diseases in 22 million individuals in the UK
10.1016/s0140-6736(22)01349-6 · 2022 · External reference
Inflammation is linked to cardiovascular risk in rheumatoid arthritis: a meta-analysis of observational studies
2015 · External reference
Explaining how “high-grade” systemic inflammation accelerates vascular risk in rheumatoid arthritis
10.1161/01.cir.0000099844.31524.05 · 2003 · External reference
Methotrexate and mortality in patients with rheumatoid arthritis: a prospective study
10.1016/s0140-6736(02)08213-2 · 2002 · External reference
Systematic review and meta-analysis of methotrexate use and risk of cardiovascular disease
10.1016/j.amjcard.2011.06.054 · 2011 · External reference
Challenges of developing a cardiovascular risk calculator for patients with rheumatoid arthritis
2016 · External reference
Risk of atrial fibrillation and stroke in rheumatoid arthritis: Danish nationwide cohort study
2016 · External reference
Thyroid hormone and heart failure: from myocardial protection to systemic regulation
2002 · External reference
Thyroid hormone and the cardiovascular system
10.1056/nejm200102153440707 · 2001 · External reference
Association between thyroid dysfunction and outcomes after acute coronary syndrome
2019 · External reference
Cardiovascular biomarkers and risk of mortality in rheumatoid arthritis
2017 · External reference
Elevated C-reactive protein levels are paradoxically associated with lower disease activity in systemic lupus erythematosus
2010 · External reference
Inflammation, aspirin, and the risk of cardiovascular disease in apparently healthy men
10.1056/nejm199704033361401 · 1997 · External reference
Inflammatory markers and cardiovascular risk: new insights from the physicians’ health study
2002 · External reference
Development and validation of improved algorithms for the assessment of global cardiovascular risk in women: the Reynolds risk score
10.1001/jama.297.6.611 · 2007 · External reference
C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis
10.1016/s0140-6736(09)61717-7 · 2010 · External reference
EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update
10.1136/annrheumdis-2016-209775 · 2017 · External reference
Cardiovascular risk in rheumatoid arthritis: recent advances in the understanding of the pivotal role of inflammation
2009 · External reference
Changes in lipid levels with inflammation and therapy in RA: a maturing paradigm
10.1038/nrrheum.2013.91 · 2013 · External reference
